CAC

Analyst Note: Camden National Corporation (CAC)

Date: June 13, 2026 Ticker: CAC

1. Structural Readiness

• Conservative Entry: $50.91
• Current Price: $51.49
• Extension: +1.1% above the conservative entry level.
• Volatility Context: The ATR at the time of the breakout was 3.2% (productive), and the current ATR is 3.1% (productive). This places the stock in a healthy volatility bucket for a small-cap financial, suggesting sufficient liquidity and structural quality without the extreme noise associated with >6% ATRs.

2. Thesis Layer

As of June 13, 2026, there is no named secular thesis attached to this name. This is a TACTICAL, setup-led opportunity. The investment case is not derived from a macroeconomic regime shift or a specific industry-wide secular tailwind identified in the current data. Instead, the conviction must be derived entirely from the quality of the technical setup (the confirmed breakout) and the immediate business fundamentals reported by management. We are judging this strictly on the strength of the price structure and the operational health of the bank as of the most recent reporting periods.

3. Business Overview

Camden National Corporation operates as a regional bank holding company serving Northern New England. Its primary business model involves attracting deposits and extending loans to consumer, institutional, municipal, non-profit, and commercial customers.

• Operations & Footprint: As of the March 31, 2026 reporting period, the company operates 72 branches across Northern New England. This footprint was significantly expanded by the acquisition of Northway Financial, Inc. on January 2, 2025, which added $971.9 million in deposits, $1.2 billion in total assets, and 17 new branches in New Hampshire.
• Product Suite: The company provides a comprehensive suite of services including commercial and consumer banking, wealth management, trust services, brokerage, investment advisory, and insurance. The lending portfolio includes commercial real estate (owner-occupied and non-owner-occupied), unsecured commercial loans (some guaranteed by the U.S.), one-to-four family residential loans, consumer loans, and home equity loans.
• Recent Operational Performance (Q1 2026):
• Net Interest Margin (NIM): Reported a NIM of 3.24% on a fully-taxable equivalent basis for the quarter ended March 31, 2026, an increase of 20 basis points year-over-year. Adjusting for fair value market accretion, the core NIM was 2.92%, up 24 basis points.
• Asset Growth: The company reported a five-year compounded annual asset growth rate of 7%, reaching $7.0 billion in total assets as of December 31, 2025.
• Loan Pipeline: Management noted a healthy production pipeline with continued growth in the home equity loan portfolio, which increased by $10.6 million during the quarter.
• Capital Position: The loan-to-deposit ratio stood at 89% as of March 31, 2026, providing a strong base to fund expected loan growth.

4. Archetype and Conviction

Archetype: Growth Leader This classification fits the company's demonstrated trajectory of asset expansion (7% CAGR), successful integration of the Northway acquisition, and the reported expansion of its loan-to-deposit ratio and NIM. The company is actively deepening engagement with small and middle-market businesses while expanding its commercial capacity.

Conviction Stack:

• Thesis Strength: Low (Tactical only; no macro thesis).
• Evidence Quality: High. The evidence base is robust, featuring specific earnings transcript quotes and SEC filings from Q1 2026 and early 2026. Key metrics like NIM expansion, loan pipeline health, and post-acquisition integration are clearly documented.
• Setup Readiness: High. The setup is confirmed and active. The price is only 1.1% above the conservative entry, indicating the move is fresh and not yet overextended.
• Rerating Potential: Moderate to High. The combination of NIM expansion (20 bps YoY) and a healthy loan pipeline suggests the market may re-rate the stock if the "low single-digit" EPS growth guidance (mentioned by management) is met or exceeded.

5. Invalidations, Strengtheners, and Gaps

Invalidation:

Strengtheners:

• Management Guidance Realization: If the company confirms the anticipated "2 to 5 basis points" NIM expansion for Q2 2026 and the "low single-digit" EPS growth range in the upcoming earnings call.
• Pipeline Execution: Continued evidence of loan pipeline build-up during the spring/summer months as management expects, specifically in the commercial and home equity sectors.
• Expense Normalization: Confirmation that the expense base has normalized following the Q1 incentive accrual true-up, as management stated.

Gaps in Evidence:

• Q2 2026 Specifics: While Q1 2026 data is robust, specific Q2 2026 financial results are not yet available as of June 13, 2026. The analysis relies on management's *expectations* for Q2 rather than actuals.
• Detailed Balance Sheet Composition: While total assets and loan-to-deposit ratios are known, granular data on the specific credit quality (non-performing loan ratios) of the newly acquired Northway portfolio is not explicitly detailed in the provided evidence snippets.
• Interest Rate Sensitivity: The evidence mentions NIM expansion but does not provide a detailed sensitivity analysis of how further rate cuts or hikes would impact the 3.24% NIM in the current environment.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key risks: Potential failure to meet Q2 NIM expansion guidance of 2-5 bps; credit quality deterioration in the expanded commercial portfolio; regulatory changes affecting regional banking margins. Sizing hint: Standard position sizing for a confirmed small-cap breakout with a wide structural stop. Expected path: Management expects NIM expansion and expense normalization in Q2; loan pipelines are building through spring/summer; asset growth trajectory remains intact. Expected horizon: 3 to 6 months for the setup to play out through the summer quarter. Failure mode to watch: A daily close below $38.50, which would invalidate the confirmed breakout structure.